Home

Pamela P Palmer

CIK 1511365 · Chief Medical Officer · last filed 2024-03-04

Pamela P Palmer is a Chief Medical Officer who has filed 35 SEC Form 4 insider transactions across 2 companies since 2011. The most recent filing shows the insider had shares withheld for taxes covering $585 of TLPH on Mar 4, 2024. Across all open-market trades the lifetime net is +$204.0K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $73.3K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$73.3K

Companies

2

Total Filings

35

Lifetime Open-Market Net

$204.0K

Filer Profile

Reported Address
C/O ACELRX PHARMACEUTICALS, INC.
351 GALVESTON DRIVE
REDWOOD CITY, CA 94063
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TLPH Chief Medical Officer 59,149 $1.24 $73.3K $0 3 2024-03-04
TALPHERA, INC. (ACRX) Delisted Chief Medical Officer 38,195 $0.86 $32.8K $204.0K 30 2023-08-25

Recent Filings

35 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-03-04 TLPH Tax (F) −450 -$585 EDGAR
2024-02-27 TLPH Grant (A) +18,000 $0 EDGAR
2024-02-13 TLPH Tax (F) −1,602 -$1.8K EDGAR
2023-08-25 TLPH Notice (144) −7,450 -$8.2K EDGAR
2023-08-25 TALPHERA, INC. (ACRX) Delisted Sell (S) −16,956 -$19.2K EDGAR
2023-08-24 TLPH Notice (144) −9,514 -$11.2K EDGAR
2023-03-06 TALPHERA, INC. (ACRX) Delisted Tax (F) −570 -$747 EDGAR
2023-02-14 TALPHERA, INC. (ACRX) Delisted Mixed +5,108 -$1.7K EDGAR
2023-02-08 TALPHERA, INC. (ACRX) Delisted Tax (F) −681 -$1.4K EDGAR
2022-03-04 TALPHERA, INC. (ACRX) Delisted Tax (F) −7,923 -$3.2K EDGAR
Showing 1–10 of 35
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.